Institutional investors purchased a net $2.5 million shares of INSM during the quarter ended December 2017 and now own 98.11% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
KLP KAPITALFORVALTNING AS Bought 2.7 Thousand shares of Insmed Inc
STATE STREET GLOBAL ADVISORS LTD... Bought 351.00 shares of Insmed Inc
FNY CAPITAL MANAGEMENT LP Sold 107.00 shares of Insmed Inc